Terms: = Prostate cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
4 results:
1. foxo1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
[TBL] [Abstract] [Full Text] [Related]
2. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.
Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM
J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353
[TBL] [Abstract] [Full Text] [Related]
3. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Hu D; Jiang L; Luo S; Zhao X; Hu H; Zhao G; Tang W
J Transl Med; 2020 Apr; 18(1):160. PubMed ID: 32264916
[TBL] [Abstract] [Full Text] [Related]
4. LITAF Enhances Radiosensitivity of Human Glioma Cells via the foxo1 Pathway.
Huang C; Chen D; Zhu H; Lv S; Li Q; Li G
Cell Mol Neurobiol; 2019 Aug; 39(6):871-882. PubMed ID: 31098771
[TBL] [Abstract] [Full Text] [Related]
